BIOMAT Database Logo BIOMAT Database Logo

Intravenous aminobisphosphonate in Paget's disease: clinical, biochemical, histomorphometric and radiological responses. 1991

A J Fenton, and D H Gutteridge, and G N Kent, and R I Price, and R W Retallack, and C I Bhagat, and G K Worth, and R I Thompson, and I G Watson, and C Barry-Walsh
Department of Endocrinology, Sir Charles Gairdner Hospital, Nedlands, Australia.

Intravenous 3-amino-1-hydroxypropylidene-1, 1-bisphosphonic acid (APD) was used to treat 26 patients with Paget's disease. Three daily dosages were studied; 20-30 mg/day in 20 patients, 45 mg/day in three patients and 60 mg/day in three patients, by daily 4-hour infusions for 2-10 days. The fasting urinary hydroxyproline excretion (HypE) declined exponentially, reaching 50% of pretreatment values at 1.92 +/- 0.16 (mean +/- SEM) days. This initial rapid decline was complete by 4 days following treatment to a mean of 28.0 +/- 3.4% of pretreatment values. Thereafter, there was no significant decline in HypE. The initial rate of decline of HypE was unchanged by increasing the daily dose of APD. Transient non-symptomatic hypocalcaemia with secondary hyperparathyroidism occurred in all patients. No adverse changes in the renal handling of calcium or phosphate, as seen with high-dose 1-hydroxyethylidene-1, 1-bisphosphonate (EHDP), were seen in any patient on any daily dose. Fever occurred in 73% of patients in the first 2 days of treatment. Overall, there was a significant fall in the lymphocyte count (P less than 0.005 febrile group, n = 19; P less than 0.02 non-febrile group, n = 7) and a fever-dependent rise in the neutrophil count (P less than 0.005 febrile group only). The occurrence of fever was associated with a more rapid decline in HypE, compared to the non-febrile group, so that HypE was significantly lower in the febrile group by day 5 (P less than 0.025). Seventy-two per cent of patients with bone and/or joint pain reported a reduction in pain.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010001 Osteitis Deformans A disease marked by repeated episodes of increased bone resorption followed by excessive attempts at repair, resulting in weakened, deformed bones of increased mass. The resultant architecture of the bone assumes a mosaic pattern in which the fibers take on a haphazard pattern instead of the normal parallel symmetry. Paget's Disease of Bone,Osseous Paget's Disease,Paget Disease of Bone,Paget Disease, Bone,Pagets Disease, Bone
D011859 Radiography Examination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film). Radiology, Diagnostic X-Ray,Roentgenography,X-Ray, Diagnostic,Diagnostic X-Ray,Diagnostic X-Ray Radiology,X-Ray Radiology, Diagnostic,Diagnostic X Ray,Diagnostic X Ray Radiology,Diagnostic X-Rays,Radiology, Diagnostic X Ray,X Ray Radiology, Diagnostic,X Ray, Diagnostic,X-Rays, Diagnostic
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D004164 Diphosphonates Organic compounds which contain P-C-P bonds, where P stands for phosphonates or phosphonic acids. These compounds affect calcium metabolism. They inhibit ectopic calcification and slow down bone resorption and bone turnover. Technetium complexes of diphosphonates have been used successfully as bone scanning agents. Bisphosphonate,Bisphosphonates
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females

Related Publications

A J Fenton, and D H Gutteridge, and G N Kent, and R I Price, and R W Retallack, and C I Bhagat, and G K Worth, and R I Thompson, and I G Watson, and C Barry-Walsh
Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study.
October 1996, Bone,
A J Fenton, and D H Gutteridge, and G N Kent, and R I Price, and R W Retallack, and C I Bhagat, and G K Worth, and R I Thompson, and I G Watson, and C Barry-Walsh
Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone.
April 1987, Clinical orthopaedics and related research,
A J Fenton, and D H Gutteridge, and G N Kent, and R I Price, and R W Retallack, and C I Bhagat, and G K Worth, and R I Thompson, and I G Watson, and C Barry-Walsh
Biochemical and clinical responses to dichloromethylene diphosphonate (Cl2MDP) in Paget's disease of bone.
October 1980, Arthritis and rheumatism,
A J Fenton, and D H Gutteridge, and G N Kent, and R I Price, and R W Retallack, and C I Bhagat, and G K Worth, and R I Thompson, and I G Watson, and C Barry-Walsh
Paget's disease: acquired resistance to one aminobisphosphonate with retained response to another.
October 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
A J Fenton, and D H Gutteridge, and G N Kent, and R I Price, and R W Retallack, and C I Bhagat, and G K Worth, and R I Thompson, and I G Watson, and C Barry-Walsh
Intravenous pamidronate in Paget's disease--response is dependent on radiographic and biochemical severity.
February 1994, Seminars in arthritis and rheumatism,
A J Fenton, and D H Gutteridge, and G N Kent, and R I Price, and R W Retallack, and C I Bhagat, and G K Worth, and R I Thompson, and I G Watson, and C Barry-Walsh
Hyperphosphatasemia in an adult. Clinical, roentgenographic, and histomorphometric findings and comparison to classical Paget's disease.
March 1986, Clinical orthopaedics and related research,
A J Fenton, and D H Gutteridge, and G N Kent, and R I Price, and R W Retallack, and C I Bhagat, and G K Worth, and R I Thompson, and I G Watson, and C Barry-Walsh
Clinical, Biochemical, Radiological, and Genetic Analyses of a Patient with VCP Gene Variant-Induced Paget's Disease of Bone.
April 2022, Calcified tissue international,
A J Fenton, and D H Gutteridge, and G N Kent, and R I Price, and R W Retallack, and C I Bhagat, and G K Worth, and R I Thompson, and I G Watson, and C Barry-Walsh
Biological and radiological responses to oral etidronate and tiludronate in Paget's disease of bone.
March 1997, Bone,
A J Fenton, and D H Gutteridge, and G N Kent, and R I Price, and R W Retallack, and C I Bhagat, and G K Worth, and R I Thompson, and I G Watson, and C Barry-Walsh
Bone remodeling and calcium metabolism: a correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget's Disease.
June 1977, Metabolism: clinical and experimental,
A J Fenton, and D H Gutteridge, and G N Kent, and R I Price, and R W Retallack, and C I Bhagat, and G K Worth, and R I Thompson, and I G Watson, and C Barry-Walsh
[Unusual radiological aspects of Paget's disease].
January 1954, Journal belge de radiologie,
Copied contents to your clipboard!